Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T (PRIME)

This study is currently recruiting participants. (see Contacts and Locations)

Verified January 2015 by Dendreon

Sponsor:

Information provided by (Responsible Party):

Dendreon

ClinicalTrials.gov Identifier:

NCT01727154

First received: November 12, 2012

Last updated: January 13, 2015

Last verified: January 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2015 (Final data collection date for primary outcome measure)